Development of Protein-Like Reference Material for Semiquantitatively Monitoring Visible Proteinaceous Particles in Biopharmaceuticals

Srivalli Telikepalli; Kristen Gonzalez; Sonia Dragulin-Otto; Dean Ripple; Michael Carrier; Mariam Khan

doi:10.5731/pdajpst.2018.008953

Research ArticleResearch

Development of Protein-Like Reference Material for Semiquantitatively Monitoring Visible Proteinaceous Particles in Biopharmaceuticals

Srivalli Telikepalli, Kristen Gonzalez, Sonia Dragulin-Otto, Dean Ripple, Michael Carrier and Mariam Khan

PDA Journal of Pharmaceutical Science and Technology September 2019, 73 (5) 418-432; DOI: https://doi.org/10.5731/pdajpst.2018.008953

Srivalli Telikepalli

1Biomolecular Measurement Division, National Institute of Standards and Technology (NIST), Gaithersburg, MD;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: srivalli.telikepalli@nist.gov

Kristen Gonzalez

2Dosage Form Design and Development, AstraZeneca, Gaithersburg, MD; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Sonia Dragulin-Otto

2Dosage Form Design and Development, AstraZeneca, Gaithersburg, MD; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Dean Ripple

1Biomolecular Measurement Division, National Institute of Standards and Technology (NIST), Gaithersburg, MD;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Michael Carrier

1Biomolecular Measurement Division, National Institute of Standards and Technology (NIST), Gaithersburg, MD;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Mariam Khan

3Analytical Sciences, AstraZeneca, Gaithersburg, MD

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
References
Info & Metrics
PDF

Article Information

vol. 73 no. 5 418-432

DOI

https://doi.org/10.5731/pdajpst.2018.008953

PubMed

31209163

Published By

Parenteral Drug Association (PDA)

Print ISSN

1079-7440

Online ISSN

1948-2124

History

Published online October 9, 2019.

Article Versions

previous version (June 17, 2019 - 04:45).
You are viewing the most recent version of this article.

Author Information

Srivalli Telikepalli1,*,
Kristen Gonzalez2,
Sonia Dragulin-Otto2,
Dean Ripple1,
Michael Carrier1 and
Mariam Khan3

¹Biomolecular Measurement Division, National Institute of Standards and Technology (NIST), Gaithersburg, MD;
²Dosage Form Design and Development, AstraZeneca, Gaithersburg, MD; and
³Analytical Sciences, AstraZeneca, Gaithersburg, MD

↵* Corresponding Author: Biomolecular Measurement Division, National Institute of Standards and Technology, Gaithersburg, MD; E-mail: srivalli.telikepalli{at}nist.gov

View Full Text

Cited By...

9 Citations
Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

Machine learning approaches to root cause analysis, characterization, and monitoring of subvisible particles in monoclonal antibody formulations

David N. Greenblott, Jingtao Zhang, Christopher P. Calderon, Theodore W. Randolph

Biotechnology and Bioengineering 2022 119 12
Monitoring of Visible Particles in Parenteral Products by Manual Visual Inspection—Reassessing Size Threshold and Other Particle Characteristics that Define Particle Visibility

Maryam Mazaheri, Miguel Saggu, Klaus Wuchner, Atanas V. Koulov, Felix Nikels, Pascal Chalus, Tapan K. Das, Patricia W. Cash, Christof Finkler, Sophia V. Levitskaya-Seaman, John Case, Jonny Parsons, Kristen Gonzalez

Journal of Pharmaceutical Sciences 2024 113 3
Recent Achievements and Current Interests in Research on the Characterization and Quality Control of Biopharmaceuticals in Japan

Akiko Ishii-Watabe, Hiroko Shibata, Hiroyuki Suetomo, Yosuke Ikeda, Srivalli Telikepalli, Masato Kiyoshi, Yu Hayashi, Takashi Muto, Yukako Tanaka, Satomi Ueda, Takafumi Iwura, Satoshi Saitoh, Michihiko Aoyama, Akira Harazono, Masashi Hyuga, Yukihiro Goda, Tetsuo Torisu, Susumu Uchiyama

Journal of Pharmaceutical Sciences 2020 109 5
An Interlaboratory Study to Identify Potential Visible Protein-Like Particle Standards

Srivalli N. Telikepalli, Michael J. Carrier, Dean C. Ripple, Greg Barnett, Ashwinkumar Bhirde, Donna Bolton, George M. Bou-Assaf, Erica Ferrari, Scott Leigh, Sophia Levitskaya-Seaman, Tim Menzen, Felix Nikels, Anna Riley, Miguel Saggu, Neha Sahni, Eric Vernooij, Klaus Wuchner

AAPS PharmSciTech 2022 24 1
Supervised and unsupervised machine learning approaches for monitoring subvisible particles within an aluminum‐salt adjuvanted vaccine formulation

David N. Greenblott, Caitlin V. Wood, Jingtao Zhang, Nelia Viza, Ramesh Chintala, Christopher P. Calderon, Theodore W. Randolph

Biotechnology and Bioengineering 2024 121 5
Features in Backgrounds of Microscopy Images Introduce Biases in Machine Learning Analyses

David N. Greenblott, Florian Johann, Jared R. Snell, Henning Gieseler, Christopher P. Calderon, Theodore W. Randolph

Journal of Pharmaceutical Sciences 2024 113 5
Morphologically-Directed Raman Spectroscopy as an Analytical Method for Subvisible Particle Characterization in Therapeutic Protein Product Quality

Minkyung Kim, Youlong Ma, Charudharshini Srinivasan, Thomas O’Connor, Srivalli N. Telikepalli, Dean C. Ripple, Scott Lute, Ashwinkumar Bhirde

Scientific Reports 2023 13 1
Comparison of Protein-like Model Particles Fabricated by Micro 3D Printing to Established Standard Particles

Ilias Amara, Oliver Germershaus, Christopher Lentes, Steffen Sass, Stephany Mamdjo Youmto, Jan Olaf Stracke, Mirjam Clemens-Hemmelmann, Anacelia Assfalg

Journal of Pharmaceutical Sciences 2024 113 8
Representative training data sets are critical for accurate machine-learning classification of microscopy images of particles formed by lipase-catalyzed polysorbate hydrolysis

David N. Greenblott, Christopher P. Calderon, Theodore W. Randolph

Journal of Pharmaceutical Sciences 2025 114 2

PreviousNext

In This Issue

PDA Journal of Pharmaceutical Science and Technology

Vol. 73, Issue 5

September/October 2019

Table of Contents
Index by Author

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on PDA Journal of Pharmaceutical Science and Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Development of Protein-Like Reference Material for Semiquantitatively Monitoring Visible Proteinaceous Particles in Biopharmaceuticals

Message Subject (Your Name) has sent you a message from PDA Journal of Pharmaceutical Science and Technology

Message Body (Your Name) thought you would like to see the PDA Journal of Pharmaceutical Science and Technology web site.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Math question * 6 + 0 =

Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

Citation Tools

Development of Protein-Like Reference Material for Semiquantitatively Monitoring Visible Proteinaceous Particles in Biopharmaceuticals

Srivalli Telikepalli, Kristen Gonzalez, Sonia Dragulin-Otto, Dean Ripple, Michael Carrier, Mariam Khan

PDA Journal of Pharmaceutical Science and Technology Sep 2019, 73 (5) 418-432; DOI: 10.5731/pdajpst.2018.008953

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Development of Protein-Like Reference Material for Semiquantitatively Monitoring Visible Proteinaceous Particles in Biopharmaceuticals

Srivalli Telikepalli, Kristen Gonzalez, Sonia Dragulin-Otto, Dean Ripple, Michael Carrier, Mariam Khan

PDA Journal of Pharmaceutical Science and Technology Sep 2019, 73 (5) 418-432; DOI: 10.5731/pdajpst.2018.008953

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Jump to section

Article
Figures & Data
References
Info & Metrics
PDF

No related articles found.

PubMed
Google Scholar

Cited By...

No citing articles found.

Google Scholar

Keywords

Proteins
protein aggregation
Proteinaceous visible particles
Protein particle standard
Ethylene tetrafluoroethylene
stability

Main menu

User menu

Search

Development of Protein-Like Reference Material for Semiquantitatively Monitoring Visible Proteinaceous Particles in Biopharmaceuticals

Article Information

Article Versions

Author Information

Cited By...

In This Issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Keywords

Readers

Author/Reviewer Information

Parenteral Drug Association, Inc.